scispace - formally typeset
Y

Ying Chen

Researcher at Zhejiang University

Publications -  8
Citations -  436

Ying Chen is an academic researcher from Zhejiang University. The author has contributed to research in topics: Ischemia & Neuroprotection. The author has an hindex of 7, co-authored 8 publications receiving 288 citations. Previous affiliations of Ying Chen include Sir Run Run Shaw Hospital.

Papers
More filters
Journal ArticleDOI

BNIP3L/NIX-mediated mitophagy protects against ischemic brain injury independent of PARK2.

TL;DR: The involvement of BNIP3L/NIX in cerebral ischemia-reperfusion (I-R)-induced mitophagy is identified and insights into mitochondrial quality control in ischemic stroke are offered.
Journal ArticleDOI

PARK2-dependent mitophagy induced by acidic postconditioning protects against focal cerebral ischemia and extends the reperfusion window

TL;DR: It is found that PARK2-dependent APC-induced mitophagy renders the brain resistant to ischemic injury, and APC treatment could be a favorable strategy to extend the thrombolytic time window for stroke therapy.
Journal ArticleDOI

Histidine provides long-term neuroprotection after cerebral ischemia through promoting astrocyte migration

TL;DR: The data indicated that a dose/stage-dependent histidine treatment, mediated by H2 receptor, promoted astrocyte migration towards the infarct core, which benefited long-term post-cerebral ischemia neurological recovery.
Journal ArticleDOI

Interleukin-1β impedes oligodendrocyte progenitor cell recruitment and white matter repair following chronic cerebral hypoperfusion.

TL;DR: The results suggest that IL-1β during the early stages following chronic cerebral hypoperfusion impedes OPC recruitment viaIL-1R1, which inhibits white matter repair and functional recovery and may have potential uses in the treatment of SIVD.
Journal ArticleDOI

Early treatment of minocycline alleviates white matter and cognitive impairments after chronic cerebral hypoperfusion.

TL;DR: There is direct evidence that early treatment is critical for minocycline to alleviate white matter and cognitive impairments after chronic cerebral hypoperfusion, which may be due to its robust effects on OPC proliferation and mature oligodendrocyte loss.